The Role of Bruton's Tyrosine Kinase in the Development and BCR/TLR-dependent Activation of AM14 Rheumatoid Factor B Cells
Overview
Affiliations
The protein kinase Btk has been implicated in the development, differentiation, and activation of B cells through its role in the BCR and TLR signaling cascades. These receptors and in particular, the BCR and either TLR7 or TLR9 also play a critical role in the activation of autoreactive B cells by RNA- or DNA-associated autoantigens. To explore the role of Btk in the development of autoreactive B cells, as well as their responses to nucleic acid-associated autoantigens, we have now compared Btk-sufficient and Btk-deficient mice that express a prototypic RF BCR encoded by H- and L-chain sdTgs. These B cells bind autologous IgG2a with low affinity and only proliferate in response to IgG2a ICs that incorporate DNA or RNA. We found that Btk-sufficient RF(+) B cells mature into naïve FO B cells, all of which express the Tg BCR, despite circulating levels of IgG2a. By contrast, a significant proportion of Btk-deficient RF(+) B cells acquires a MZ or MZ precursor phenotype. Remarkably, despite the complete inability of RF(+) Xid/y B cells to respond to F(ab')2 anti-IgM, RF(+) Xid/y B cells could respond well to autoantigen-associated ICs. These data reveal unique features of the signaling cascades responsible for the activation of autoreactive B cells.
Bracken S, Suthers A, DiCioccio R, Su H, Anand S, Poe J Blood Adv. 2023; 8(3):667-680.
PMID: 38113462 PMC: 10839617. DOI: 10.1182/bloodadvances.2023010362.
Nundel K, Mande P, Moses S, Busto P, Cullen J, Schmidt M J Immunol. 2019; 203(8):2055-2062.
PMID: 31534009 PMC: 7078032. DOI: 10.4049/jimmunol.1900499.
Satterthwaite A Front Immunol. 2018; 8:1986.
PMID: 29403475 PMC: 5786522. DOI: 10.3389/fimmu.2017.01986.
TLR7/TLR9- and B Cell Receptor-Signaling Crosstalk: Promotion of Potentially Dangerous B Cells.
Suthers A, Sarantopoulos S Front Immunol. 2017; 8:775.
PMID: 28751890 PMC: 5507964. DOI: 10.3389/fimmu.2017.00775.
Giles J, Neves A, Marshak-Rothstein A, Shlomchik M JCI Insight. 2017; 2(4):e90870.
PMID: 28239656 PMC: 5313065. DOI: 10.1172/jci.insight.90870.